On this page
IPEX syndrome
IPEX syndrome is an uncommon condition, mainly affecting males, where the immune system attacks the body's own tissues. It typically presents in infancy with a combination of severe autoimmune symptoms affecting several organs.
Available at Jeen Health
Clinical tests that include this
Overview
IPEX syndrome, which stands for Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome, is a rare and serious genetic condition. It is caused by a problem with how the immune system functions, specifically affecting its ability to distinguish between the body's own cells and foreign invaders [PMID:33675037]. This leads to an autoimmune response, where the immune system mistakenly attacks healthy tissues and organs. The condition primarily affects males, with symptoms often appearing shortly after birth.
Symptoms & clinical features
The symptoms of IPEX syndrome are typically severe and can affect multiple body systems. One of the most common features is severe enteropathy, which is inflammation of the intestines, leading to chronic, watery diarrhoea, often with blood and difficulty absorbing nutrients (malabsorption) [PMID:25966675]. Another key symptom is endocrinopathy, meaning problems with glands that produce hormones; type 1 diabetes is frequently seen, where the immune system attacks the insulin-producing cells in the pancreas. Skin conditions like eczema and other autoimmune disorders affecting the blood cells (such as anaemia or thrombocytopenia) are also common [PMID:33675037]. Affected individuals are also prone to severe, recurrent infections because their immune system is not working correctly.
Video: Genetics 101
Affected organs
IPEX syndrome significantly affects several organ systems. The gastrointestinal tract is severely impacted, leading to chronic diarrhoea and malabsorption. The endocrine system is also commonly affected, particularly the pancreas, resulting in type 1 diabetes. The skin frequently shows signs of autoimmune reactions, often appearing as eczema. Blood cells can also be targeted, leading to conditions like autoimmune haemolytic anaemia or immune thrombocytopenia. Additionally, the liver and kidneys can sometimes be affected by the immune system's attack.
Risks & severity
IPEX syndrome is a severe condition with a wide range of clinical presentations, but generally, it carries significant risks. If left untreated, the severe autoimmune reactions can be life-threatening. The exact prevalence of IPEX syndrome is not well established, but it is considered a very rare disorder. Symptoms typically begin in infancy, often within the first year of life. The severity can vary, but most individuals experience chronic, severe symptoms that require ongoing medical management. Early diagnosis and intervention are crucial for improving outcomes.
Genetic causes
IPEX syndrome is primarily caused by pathogenic variants in the FOXP3 gene. The FOXP3 gene provides instructions for making a protein called Forkhead box P3, which is a critical regulator of the immune system [PMID:25966675]. Specifically, the FOXP3 protein is essential for the development and function of regulatory T-cells (Tregs). Tregs are a type of immune cell that helps to suppress excessive immune responses and prevent the immune system from attacking the body's own tissues. When there are pathogenic changes in the FOXP3 gene, the FOXP3 protein may not be produced correctly or may not function properly. This leads to a deficiency or dysfunction of regulatory T-cells, causing the immune system to become overactive and attack healthy organs, resulting in the autoimmune features seen in IPEX syndrome.
- FOXP3 forkhead box P3
Inheritance pattern
IPEX syndrome has an X-linked recessive (XLR) inheritance pattern. This means the FOXP3 gene is located on the X chromosome. Males have one X and one Y chromosome, so if their single X chromosome carries a pathogenic variant in FOXP3, they will develop the condition. Females have two X chromosomes; if one X chromosome carries a pathogenic variant, they are typically carriers and usually do not show symptoms because their other X chromosome provides a functional copy of the gene. However, female carriers can, in rare cases, experience milder symptoms. Each son of a female carrier has a 50% chance of inheriting the pathogenic variant and developing IPEX syndrome, while each daughter has a 50% chance of being a carrier.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
Diagnosis & testing
Diagnosis of IPEX syndrome is typically suspected based on a combination of characteristic clinical features, such as severe enteropathy, type 1 diabetes, and eczema, particularly in an infant male. Genetic testing is used to confirm the diagnosis and involves analysing the FOXP3 gene for pathogenic variants [PMID:25966675]. In the UK, genetic testing for suspected cases of IPEX syndrome would typically be arranged by a clinical geneticist or immunologist. This falls under the NHS Genomic Medicine Service (GMS) pathways, often through specific R-codes for severe combined immunodeficiency (R105) or severe autoimmune disease, which would encompass IPEX syndrome. Referral for genetic testing usually comes from specialist paediatricians or immunologists.
Management & lifestyle
Management of IPEX syndrome is complex and aims to control the severe autoimmune reactions and manage symptoms, as there is currently no cure. Treatment strategies often include immunosuppressive medications to dampen the immune system's attack on the body's tissues. Nutritional support is vital due to severe malabsorption. Haematopoietic stem cell transplantation (HSCT) is considered a potential curative treatment for some individuals, where the affected bone marrow is replaced with healthy donor cells, allowing for the production of functional regulatory T-cells. This is a high-risk procedure and its suitability is carefully assessed. Ongoing monitoring by a multidisciplinary team, including immunologists, endocrinologists, gastroenterologists, and clinical geneticists, is essential within the NHS framework to manage the various manifestations of the condition.
UK care pathway
In the UK, individuals suspected of having IPEX syndrome typically enter the NHS Genomic Medicine Service (GMS) pathway. Referral to clinical genetics services or specialist immunology centres is key. Clinical geneticists and genetic counsellors provide information, support, and facilitate appropriate genetic testing, often utilising NHS R-codes like R105 (for severe combined immunodeficiency, which can include IPEX) or other relevant panels for autoimmune conditions. Genetic counselling is vital for affected families to understand the inheritance pattern and implications for other family members.
Frequently asked questions
What does 'X-linked recessive' mean for IPEX syndrome?
X-linked recessive means the gene associated with IPEX syndrome is on the X chromosome. Males, with only one X chromosome, are typically affected if they inherit the altered gene. Females usually carry the altered gene without symptoms, but can pass it on to their children.
How rare is IPEX syndrome?
IPEX syndrome is considered a very rare genetic disorder. The exact number of affected individuals is not precisely known, but it is uncommon worldwide.
Can females be affected by IPEX syndrome?
While IPEX syndrome predominantly affects males, females who are carriers of a pathogenic FOXP3 gene variant can, in rare instances, develop milder symptoms due to a process called skewed X-chromosome inactivation.
What is the role of the FOXP3 gene?
The FOXP3 gene is crucial for making a protein that helps control the immune system. It ensures the immune system does not mistakenly attack the body's own healthy tissues. When this gene is not working correctly, it leads to the autoimmune issues seen in IPEX syndrome.
Is there a cure for IPEX syndrome?
Currently, the main potential curative treatment for IPEX syndrome is a haematopoietic stem cell transplant (HSCT). However, this is a complex procedure, and treatment often focuses on managing symptoms and immune system dysfunction with various medications.
References
- Bacchetta R, Roncarolo MG. IPEX syndrome from diagnosis to cure, learning along the way. The Journal of allergy and clinical immunology. 2024. PMID: 38040040
- Sumida TS, Cheru NT, Hafler DA. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nature reviews. Immunology. 2024. PMID: 38374298
- Adam MP, Bick S, Mirzaa GM. IPEX Syndrome. 1993. PMID: 20301297
- Bennett CL, Christie J, Ramsdell F. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature genetics. 2001. PMID: 11137993
- Ben-Skowronek I. IPEX Syndrome: Genetics and Treatment Options. Genes. 2021. PMID: 33668198
- Voarino M, Consonni F, Gambineri E. Expanding the spectrum of IPEX: from new clinical findings to novel treatments. Current opinion in allergy and clinical immunology. 2024. PMID: 39475830
- Bekis Bozkurt H, Bayram Catak F, Sahin A. Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey. Journal of clinical immunology. 2024. PMID: 39283523
- Barzaghi F, Passerini L. IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis. Frontiers in pediatrics. 2021. PMID: 33692972